Exoskeleton therapy improves mobility, cognition and brain connectivity in people with multiple sclerosis (MS), according to the findings of a new study. A team of (MS) experts led a pilot randomised controlled trial of robotic-exoskeleton assisted exercise rehabilitation (REAER) effects on mobility, cognition, and brain connectivity in people with substantial MS-related disability. Their results showed that REAER is likely an effective intervention, and is a promising therapy for improving the lives of those with MS. It is common for people with MS to experience impairments in both mobility and cognition, and few therapies exist to manage the range of debilitating symptoms. This lack of treatment options is a major problem for people with MS, especially those with substantial MS-related neurological disabilities. Research suggesting that even a single exercise rehabilitation intervention can improve both mobility and cognition. Moreover, adaptive interventions lack key interactions between patients and therapists that may improve efficacy. In a study of 10 participants with significant MS-related neurological disability, researchers explored the use of robotic exoskeletons to manage symptoms. Rehabilitation exercise using robotic exoskeletons is a relatively new approach that enables participants to walk over-ground in a progressive regimen that involves close engagement with a therapist.